Back to search

Sweden· SE-20140403000055

Actilyse Pulver och vätska till injektions-/infusionsvätska, lösning

A medicinal product, registered in Sweden by Orifarm AB.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedActilyse Pulver och vätska till injek…ATC—REGISTER NO.SE-20140403000055PACKS LISTED1CHECKEDJune 25, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Manufacturer
Orifarm AB
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
June 25, 2026

Packs & prices · 1

  • se_varunummer
    20140403000055

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f0457c64-4f20-4ef4-a27b-a006c9f6ae5e
GET /v1/drugs/f0457c64-4f20-4ef4-a27b-a006c9f6ae5e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL"
  ],
  "se_npl_id": "20140403000055",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20140403000055",
  "product_doc_link": "https://docetp.mpa.se/LMF/Actilyse%20powder%20and%20solvent%20for%20solution%20for%20injection%20or%20infusion%20NO%20PL_09001bee807a1029.pdf"
}

See everything about Actilyse.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.